Merdad Parsey - Mar 10, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Medical Officer
Signature
/s/ Amy Kim by Power of Attorney for Merdad Parsey
Stock symbol
GILD
Transactions as of
Mar 10, 2023
Transactions value $
-$423,576
Form type
4
Date filed
3/13/2023, 09:09 PM
Previous filing
Mar 2, 2023
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3.46K +4.93% 73.6K Mar 10, 2023 Direct F1
transaction GILD Common Stock Options Exercise +8K +10.87% 81.6K Mar 10, 2023 Direct F1
transaction GILD Common Stock Tax liability -$424K -5.33K -6.53% $79.50 76.3K Mar 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3.46K -7.83% 40.6K Mar 10, 2023 Common Stock 3.46K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -8K -19.68% 32.6K Mar 10, 2023 Common Stock 8K Direct F1, F3
transaction GILD Restricted Stock Unit Award +16.7K +51.05% 49.3K Mar 10, 2023 Common Stock 16.7K Direct F1, F3
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +76K $0.00 76K Mar 10, 2023 Common Stock 76K $79.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4 The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.